These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 10801919)

  • 1. Bioavailabilities of quercetin-3-glucoside and quercetin-4'-glucoside do not differ in humans.
    Olthof MR; Hollman PC; Vree TB; Katan MB
    J Nutr; 2000 May; 130(5):1200-3. PubMed ID: 10801919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and bioavailability of quercetin glycosides in humans.
    Graefe EU; Wittig J; Mueller S; Riethling AK; Uehleke B; Drewelow B; Pforte H; Jacobasch G; Derendorf H; Veit M
    J Clin Pharmacol; 2001 May; 41(5):492-9. PubMed ID: 11361045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man.
    Hollman PC; Bijsman MN; van Gameren Y; Cnossen EP; de Vries JH; Katan MB
    Free Radic Res; 1999 Dec; 31(6):569-73. PubMed ID: 10630681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats.
    Makino T; Shimizu R; Kanemaru M; Suzuki Y; Moriwaki M; Mizukami H
    Biol Pharm Bull; 2009 Dec; 32(12):2034-40. PubMed ID: 19952424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside.
    Sesink AL; O'Leary KA; Hollman PC
    J Nutr; 2001 Jul; 131(7):1938-41. PubMed ID: 11435510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respective bioavailability of quercetin aglycone and its glycosides in a rat model.
    Morand C; Manach C; Crespy V; Remesy C
    Biofactors; 2000; 12(1-4):169-74. PubMed ID: 11216481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man.
    Hollman PC; van Trijp JM; Buysman MN; van der Gaag MS; Mengelers MJ; de Vries JH; Katan MB
    FEBS Lett; 1997 Nov; 418(1-2):152-6. PubMed ID: 9414116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
    Arts IC; Sesink AL; Faassen-Peters M; Hollman PC
    Br J Nutr; 2004 Jun; 91(6):841-7. PubMed ID: 15182387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer.
    Boyer J; Brown D; Liu RH
    Nutr J; 2005 Jan; 4():1. PubMed ID: 15644141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma.
    Morand C; Manach C; Crespy V; Remesy C
    Free Radic Res; 2000 Nov; 33(5):667-76. PubMed ID: 11200097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway.
    Gee JM; DuPont MS; Day AJ; Plumb GW; Williamson G; Johnson IT
    J Nutr; 2000 Nov; 130(11):2765-71. PubMed ID: 11053519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans.
    Murota K; Matsuda N; Kashino Y; Fujikura Y; Nakamura T; Kato Y; Shimizu R; Okuyama S; Tanaka H; Koda T; Sekido K; Terao J
    Arch Biochem Biophys; 2010 Sep; 501(1):91-7. PubMed ID: 20638359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and excretion of conjugated flavonols, including quercetin-4'-O-beta-glucoside and isorhamnetin-4'-O-beta-glucoside by human volunteers after the consumption of onions.
    Aziz AA; Edwards CA; Lean ME; Crozier A
    Free Radic Res; 1998 Sep; 29(3):257-69. PubMed ID: 9802557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A; Fischer H; Römer A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of quercetin and quercetin 3-glucoside from whole onion and apple peel extracts by Caco-2 cell monolayers.
    Boyer J; Brown D; Liu RH
    J Agric Food Chem; 2004 Nov; 52(23):7172-9. PubMed ID: 15537334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Processed Onions on the Plasma Concentration of Quercetin in Rats and Humans.
    Kashino Y; Murota K; Matsuda N; Tomotake M; Hamano T; Mukai R; Terao J
    J Food Sci; 2015 Nov; 80(11):H2597-602. PubMed ID: 26375490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HPLC investigation of antioxidant components in Solidago herba].
    Apáti P; Houghton PJ; Kéry A
    Acta Pharm Hung; 2004; 74(4):223-31. PubMed ID: 16316050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine.
    Wolffram S; Blöck M; Ader P
    J Nutr; 2002 Apr; 132(4):630-5. PubMed ID: 11925453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of [2-14C]quercetin-4'-glucoside in rats.
    Graf BA; Mullen W; Caldwell ST; Hartley RC; Duthie GG; Lean ME; Crozier A; Edwards CA
    Drug Metab Dispos; 2005 Jul; 33(7):1036-43. PubMed ID: 15833931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
    Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
    Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.